Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Saravanakumar Marimuthu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3640-5408; OpenAlex author ID A5067877890. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 8

  1. Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218276↗
  2. Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-026-03896-5↗
  3. Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2026.04.041↗
  4. PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. Co-author DOI 10.1186/s40170-024-00354-2↗
  5. Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2022.215922↗
  6. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41388-022-02493-6↗
  7. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion. Co-author DOI 10.1158/1541-7786.mcr-21-0888↗
  8. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-020-01518-2↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 8 shared papers, 2021–2026 · strength 1.40
  2. Sanchita Rauth · 7 shared papers, 2021–2026 · strength 1.16
  3. Moorthy Palanimuthu Ponnusamy · 7 shared papers, 2021–2026 · strength 1.16
  4. Palanisamy Nallasamy · 5 shared papers, 2021–2026 · strength 0.94
  5. Zahraa Wajih Alsafwani · 4 shared papers, 2024–2026 · strength 0.94
  6. Kavita B. Mallya · 5 shared papers, 2021–2026 · strength 0.82
  7. Jesse L. Cox · 4 shared papers, 2022–2026 · strength 0.80
  8. Rama Krishna Nimmakayala · 5 shared papers, 2021–2024 · strength 0.68
  9. Ashu Shah · 4 shared papers, 2022–2026 · strength 0.62
  10. Pranita Atri · 4 shared papers, 2022–2026 · strength 0.60
  11. Parthasarathy Seshacharyulu · 3 shared papers, 2022–2026 · strength 0.49
  12. Venkatesh Varadharaj · 2 shared papers, 2026 · strength 0.48
  13. Namita Bhyravbhatla · 3 shared papers, 2022–2026 · strength 0.48
  14. Michael Anthony Hollingsworth · 3 shared papers, 2021–2026 · strength 0.45
  15. Paul M. Grandgenett · 3 shared papers, 2021–2026 · strength 0.45
  16. Subodh M. Lele · 2 shared papers, 2021–2026 · strength 0.36
  17. Geoffrey A. Talmon · 2 shared papers, 2022–2026 · strength 0.33
  18. Frank Leon · 2 shared papers, 2021–2026 · strength 0.32
  19. Jean L. Grem · 2 shared papers, 2021–2026 · strength 0.32
  20. Krystal Villalobos-Ayala · 1 shared paper, 2026 · strength 0.24
  21. Imran Khan · 1 shared paper, 2026 · strength 0.24
  22. Margaret A. Park · 1 shared paper, 2026 · strength 0.24
  23. Barbara Ann Centeno · 1 shared paper, 2026 · strength 0.24
  24. Mokenge Peter Malafa · 1 shared paper, 2026 · strength 0.24
  25. Sushil Kumar · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.